MedTrace Logo

Single-dose Nicotine Pharmacokinetics With Four Oral Nicotine Replacement Products

NCT01234896 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 44

Last updated 2012-07-10

No results posted yet for this study

Summary

Single-dose nicotine pharmacokinetics with four oral nicotine replacement products. A study in healthy smokers.

Conditions

  • Tobacco Dependence

Interventions

DRUG

Nicotine Medicated Gum

Dosage Form: Gum; Dosage: 6 mg; Frequency: Once; Duration: 30 minutes

DRUG

4 mg Nicotine Gum

Dosage Form: Gum; Dosage: 4 mg; Frequency: Once; Duration: 30 minutes

DRUG

2 mg Nicotine Gum

Dosage Form: Gum; Dosage: 2 mg; Frequency: Once; Duration: 30 minutes

DRUG

4 mg Nicotine Lozenge

Dosage Form: Lozenge; Dosage: 4 mg; Frequency: Once; Duration: until dissolved

Sponsors & Collaborators

  • McNeil AB

    lead INDUSTRY

Principal Investigators

  • Elisabeth Kruse, PhD · McNeil AB

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Max Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-10-31
Primary Completion
2010-11-30
Completion
2010-12-31

Countries

  • Sweden

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01234896 on ClinicalTrials.gov